Results 21 to 30 of about 3,545 (199)

Situation of anti-fungal resistance of species of the genus Candida in Peru

open access: yesRevista Peruana de Medicina Experimental y Salud Pública, 2018
We are currently witnessing a constant and ongoing change of the epidemiological pictures of yeast resistance to antifungal agents, related to the type of host, etiology of the disease, the microorganism involved, and its mechanisms of resistance.
Susana Zurita Macalupú
doaj   +1 more source

Absence of intraocular infections after hematopoietic stem cell transplantation at a single center: The experience with current preventive regimens [PDF]

open access: yes, 2014
Purpose: To investigate the prevalence of intraocular infections after allogeneic stem cell transplantation (allo-SCT). Methods: The study design was a single institutional retrospective noncomparative cohort of 135 consecutive patients in 2006 and 2007 ...
Boome, L.C.J. (Liane ) te   +4 more
core   +1 more source

Uso do voriconazol oral como tratamento adjuvante da infecção fúngica grave da córnea: relato de caso [PDF]

open access: yes, 2006
A case of Aspergillus flavus keratitis was successfully treated with oral voriconazole and penetrating keratoplasty after conventional antifungal medical therapy failure.O presente trabalho descreve o emprego do voriconazol sistêmico como adjuvante no ...
Freda, Roberto
core   +2 more sources

Genetic polymorphism of cytochrome p450 (2C19) enzyme in Iranian Turkman ethnic group [PDF]

open access: yes, 2013
Objective: Different findings indicate that CYP2C plays a clinical role in determining interindividual and interethnic differences in drug effectiveness. The ethnic differences in the frequency of CYP2C19 mutant alleles continue to be a significant study
Ataby, O.A.   +4 more
core   +2 more sources

Coinfection of Invasive Pulmonary Aspergillosis and Pneumocystis Jiroveci Pneumonia in a Non-HIV Patient [PDF]

open access: yes, 2007
Invasive pulmonary aspergillosis (IPA) and pneumocystis jiroveci pneumonia (PCP) are life-threatening opportunistic infections that occur in immunocompromised hosts.
Hisada, Takeshi   +8 more
core   +1 more source

Trichosporon asahii an emerging etiologic agent of fungal infection and colonization in heart failure patients in intensive care unit: case report and literature review [PDF]

open access: yes, 2008
JUSTIFICATIVA E OBJETIVOS: As infecções fúngicas por Trichosporon Asahii têm sido cada vez mais freqüentes nas últimas duas décadas. Quadros graves com alta mortalidade são tradicionalmente descritos em pacientes neutropênicos com câncer. Recentemente, a
ARAÚJO, Hélia Beatriz Nunes de   +7 more
core   +2 more sources

Cuerpo extraño vegetal intrabronquial con colonización por Aspergillus [PDF]

open access: yesRevista SOCAMPAR, 2019
La aspiración de cuerpo extraño en la vía aérea es poco frecuente en adultos. Es poco probable que se relate el episodio de atragantamiento espontáneamente como antecedente claro y suele pasar inadvertido.
Arroyo-Cózar M,   +2 more
doaj  

FUSARIOSE EM PACIENTE COM LINFOMA LINFOBLÁSTICO T - RELATO DO CASO

open access: yesHematology, Transfusion and Cell Therapy, 2023
Objetivo: Relatar um caso de infecção fúngica invasiva por fusarium em paciente com Linfoma Linfoblástico T. Relato de caso: P. F. M. C., 38 anos, sexo feminino, deu entrada em nosso serviço em fevereiro de 2021 com diagnóstico de Linfoma Linfoblástico T
FC Domingos   +8 more
doaj   +1 more source

Voriconazole

open access: yesReactions Weekly, 2006
Voriconazole (VRZ) is a second-generation triazole antifungal agent active against many species of Aspergillus and Candida and acts by inhibiting ergosterol synthesis. VRZ has less nephrotoxicity and less infusion-related toxicity than that of Amphotericin B. Oral and parental formulation have similar pharmacokinetics and thus oral formulation shortens
Rahul, Naithani, Rajat, Kumar
openaire   +3 more sources

PS1214 INFECTIOUS COMPLICATIONS FOLLOWING ARI‐0001 CELL (A3B1:CD8:4–1BB:CD3Z CART19) TREATMENT IN ADULT AND PEDIATRIC PATIENTS WITH CD19+ RELAPSED / REFRACTORY MALIGNANCIES

open access: yesHemaSphere, Volume 3, Issue S1, Page 553-554, June 2019., 2019
Background: Several chimeric antigen receptor products targeting CD19 are either approved or in development for the treatment of acute lymphoblastic leukemia (ALL) and non‐Hodgkin's lymphoma (NHL). Nevertheless, information on infections and immune impairment caused by this procedure (lymphodepletion chemotherapy, neutropenia, B‐cell aplasia and ...
V. Ortiz‐Maldonado   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy